These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2853423)

  • 1. Prostaglandins as reducing agents: a model of adenylate cyclase activation?
    Peterson DA; Kelly B; Mehta N; Gerrard JM
    Prostaglandins; 1988 Nov; 36(5):667-71. PubMed ID: 2853423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis toxin abolishes the inhibitory effects of prostaglandins E1, E2, I2 and F2 alpha on hormone-induced cAMP accumulation in cultured hepatocytes.
    Melien O; Winsnes R; Refsnes M; Gladhaug IP; Christoffersen T
    Eur J Biochem; 1988 Mar; 172(2):293-7. PubMed ID: 2832160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
    Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
    J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGI2-sensitive human adenylate cyclase in biopsy specimens of corpus, antral and duodenal mucosa.
    Simon B; Kather H
    Digestion; 1980; 20(2):111-4. PubMed ID: 6988259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature.
    Chaudhari A; Gupta S; Kirschenbaum MA
    Biochim Biophys Acta; 1990 Jul; 1053(2-3):156-61. PubMed ID: 2166584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of prostaglandins with subpopulations of ovine luteal cells. I. Stimulatory effects of prostaglandins E1, E2 and I2.
    Fitz TA; Hoyer PB; Niswender GD
    Prostaglandins; 1984 Jul; 28(1):119-26. PubMed ID: 6091185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
    Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The existence of distinct classes of prostaglandin E2 receptors mediating adenylate cyclase and phospholipase C pathways in osteoblastic clone MC3T3-E1.
    Toriyama K; Morita I; Murota S
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):15-20. PubMed ID: 1321447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
    Anderson LE; Schultz MK; Wiltbank MC
    J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of a disulfide bond by beta-adrenergic agonists: evidence in support of a general "reductive activation" hypothesis for the mechanism of action of adrenergic agents.
    Peterson DA; Gerrard JM
    Med Hypotheses; 1987 Jan; 22(1):45-9. PubMed ID: 2882407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 action on adenylate cyclase activity and membrane lipids in platelets.
    Mruk J; Bakardjiev A; Burgermeister W
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):745-56. PubMed ID: 6957369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of prostaglandin E1, E2 and F2 alpha on the changes in the adenylate cyclase activities of rabbit urinary tract tissues].
    Kondo S; Morita T; Hirano S
    J Smooth Muscle Res; 1993 Feb; 29(1):29-36. PubMed ID: 8389621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1, E2, and F2 alpha in human milk and plasma.
    Shimizu T; Yamashiro Y; Yabuta K
    Biol Neonate; 1992; 61(4):222-5. PubMed ID: 1610950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of peripheral collateral arteries in the dog to prostaglandins E1, E2, F2 alpha, and I2 (prostacyclin).
    Williams PB; Joyner JH
    J Cardiovasc Pharmacol; 1982; 4(5):784-90. PubMed ID: 6182410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandin receptors and prostaglandin metabolism in the terminal circulation of the brain].
    Wasinger T
    Wien Klin Wochenschr; 1989 Dec; 101(23):821-4. PubMed ID: 2514495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
    Costall B; Holmes SW; Kelly ME; Naylor RJ
    Br J Pharmacol; 1985 Aug; 85(4):943-9. PubMed ID: 3862460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.